Mapping dopaminergic projections in the human brain with resting-state fMRI

  1. Marianne Oldehinkel  Is a corresponding author
  2. Alberto Llera
  3. Myrthe Faber
  4. Ismael Huertas
  5. Jan K Buitelaar
  6. Bastiaan R Bloem
  7. Andre F Marquand
  8. Rick Helmich
  9. Koen V Haak
  10. Christian F Beckmann
  1. Radboud University Medical Centre, Netherlands
  2. Institute of Biomedicine of Seville (IBiS), Spain
  3. Radboud University Medical Center, Netherlands

Abstract

The striatum receives dense dopaminergic projections making it a key region of the dopaminergic system. Its dysfunction has been implicated in various conditions including Parkinson's disease (PD) and substance use disorder. However, the investigation of dopamine-specific functioning in humans is problematic as current MRI approaches are unable to differentiate between dopaminergic and other projections. Here, we demonstrate that 'connectopic mapping' -a novel approach for characterizing fine-grained, overlapping modes of functional connectivity- can be used to map dopaminergic projections in striatum. We applied connectopic mapping to resting-state functional MRI data of the Human Connectome Project (population cohort; N=839) and selected the second-order striatal connectivity mode for further analyses. We first validated its specificity to dopaminergic projections by demonstrating a high spatial correlation (r=0.884) with dopamine transporter availability -a marker of dopaminergic projections- derived from DaT SPECT scans of 209 healthy controls. Next, we obtained the subject-specific second-order modes from 20 controls, and 39 PD patients scanned under placebo and under dopamine replacement therapy (L-DOPA), and show that our proposed dopaminergic marker tracks PD diagnosis, symptom severity and sensitivity to L-DOPA. Finally, across 30 daily alcohol users and 38 daily smokers, we establish strong associations with self-reported alcohol and nicotine use. Our findings provide evidence that the second-order mode of functional connectivity in striatum maps onto dopaminergic projections, tracks inter-individual differences in PD symptom severity and L-DOPA sensitivity, and exhibits strong associations with levels of nicotine and alcohol use, thereby offering a new biomarker for dopamine-related (dys)function in the human brain.

Data availability

We made use of publicly available data from the Human Connectome Project (HCP) dataset, from publicly available data from the Parkinson Progression Marker Initiative (PPMI) dataset, and from a local PD dataset that was part of a clinical trial.See https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release for access to the HCP data. The subject identifiers from the HCP dataset used in our first analysis can be found in Appendix 2 - Table 4. Please note that the subject identifiers from the subset of HCP subjects included in the nicotine-use and alcohol-use analyses cannot be provided, since the access to information about substance use is restricted. For more information about applying to get access to the HCP restricted data and for the HCP restricted data use terms see: https://www.humanconnectome.org/study/hcp-young-adult/document/wu-minn-hcp-consortium-restricted-data-use-terms.For access to the PPMI dataset, see https://www.ppmi-info.org/access-data-specimens/download-data. The subject identifiers from the PPMI dataset used in our analyses can be found in Appendix 2 - Tables 5 and 6.All derived and anonymized individual data from our local PD dataset are available at the Donders Repository: https://data.donders.ru.nl/.The code used for the connectopic mapping procedure in all three datasets is available at the following Github repository: https://github.com/koenhaak/congrads.In addition, for supplementary analyses, we further used PET scans available in the JuSpace Toolbox: https://github.com/ juryxy/JuSpace.

The following previously published data sets were used

Article and author information

Author details

  1. Marianne Oldehinkel

    Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands
    For correspondence
    marianne.oldehinkel@donders.ru.nl
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7573-0548
  2. Alberto Llera

    Donders Institute for Brain, Cognition and Behaviour, Radboud, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8358-8625
  3. Myrthe Faber

    Donders Institute for Brain, Cognition and Behaviour, Radboud, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  4. Ismael Huertas

    Institute of Biomedicine of Seville (IBiS), Seville, Spain
    Competing interests
    No competing interests declared.
  5. Jan K Buitelaar

    Donders Institute for Brain, Cognition and Behaviour, Radboud, Radboud University Medical Center, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  6. Bastiaan R Bloem

    Department of Neurology, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  7. Andre F Marquand

    Donders Institute for Brain, Cognition and Behaviour, Radboud, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5903-203X
  8. Rick Helmich

    Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  9. Koen V Haak

    Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    No competing interests declared.
  10. Christian F Beckmann

    Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands
    Competing interests
    Christian F Beckmann, C.F.B. is director and shareholder in SBGneuro Ltd..

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vidi Grant No. 864-12-004)

  • Christian F Beckmann

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vici Grant No. 17854)

  • Christian F Beckmann

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vidi Grant No. 016.156.415)

  • Andre F Marquand

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Veni Grant No. 016.171.068)

  • Koen V Haak

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Veni Grant No. 91617077)

  • Rick Helmich

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-CAS Grant No. 012-200-013)

  • Christian F Beckmann

ZonMw (Rubicon Grant No. 452172019)

  • Marianne Oldehinkel

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants from whom data was used in this manuscript, provided written informed consent (and consent to publish) according to the declaration of Helsinki. For the HCP dataset ethical approval was given by the Washington University Institutional Review Board (IRB), for the PPMI dataset ethical approval was obtained locally at each of the participating sites, and for our local PD dataset ethical approval was obtained from the local ethical committee (Commissie Mensgebonden Onderzoek MO Arnhem Nijmegen, CMO 2014/014).

Copyright

© 2022, Oldehinkel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,846
    views
  • 633
    downloads
  • 26
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marianne Oldehinkel
  2. Alberto Llera
  3. Myrthe Faber
  4. Ismael Huertas
  5. Jan K Buitelaar
  6. Bastiaan R Bloem
  7. Andre F Marquand
  8. Rick Helmich
  9. Koen V Haak
  10. Christian F Beckmann
(2022)
Mapping dopaminergic projections in the human brain with resting-state fMRI
eLife 11:e71846.
https://doi.org/10.7554/eLife.71846

Share this article

https://doi.org/10.7554/eLife.71846

Further reading

    1. Neuroscience
    Jakob Rupert, Dragomir Milovanovic
    Insight

    By influencing calcium homeostasis, local protein synthesis and the endoplasmic reticulum, a small protein called Rab10 emerges as a crucial cytoplasmic regulator of neuropeptide secretion.

    1. Neuroscience
    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.